Evaluation of current and emerging endoluminal robotic platforms using the IDEAL framework.
Loading...
Authors
Shah, Diya
Tesfai, Freweini Martha
Boal, Matthew
Arezzo, Alberto
Francis, Nader
Issue Date
2025-02-21
Type
Journal Article
Review
Review
Language
en
Keywords
IDEAL framework , Robotic-assisted endoluminal systems , evaluation , minimally invasive surgery , robotics
Alternative Title
Abstract
Background: Robotic-assisted endoluminal systems are rapidly evolving within the field of minimally invasive surgery. The IDEAL framework (Idea, Development, Exploration, Assessment, and Surveillance) can be used to evaluate novel technologies. This review provides a summary of current and emerging endoluminal systems using the IDEAL framework.
Methods: A scoping review was conducted to include all existing and developing robotic-assisted endoluminal systems. Data was collected via virtual interviews, questionnaires, biomedical databases, company websites, and peer-reviewed articles. Key metrics were reported, enabling the assignment of each system to an IDEAL stage.
Results: The review identified 17 distinct systems from 16 companies. Nine systems received regulatory approval in their respective countries. Our evaluation showed that two systems were at the pre-IDEAL Stage 0. Seven systems were in the Idea stage (Stage 1), six systems were in the Development stage (Stage 2) and two systems completed Stage 3. No system underwent long-term study evaluation (Stage 4).
Conclusions: There is a gap in long-term clinical data of robotic-assisted endoluminal systems, indicated by the absence of systems at Stage 4. Collaborative efforts amongst the medical community, regulatory bodies, and industry specialists are vital to ensure the delivery of evidence-based medicine in the discipline of robotics.
Description
� 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Citation
Shah, D.; Tesfai, FM.; Boal, M.; Arezzo, A. and Francis, N. (2025) 'Evaluation of current and emerging endoluminal robotic platforms using the IDEAL framework', Minimally Invasive Therapy & Allied Technologies 34(4) pp. 253-266. Available At: https://doi.org/10.1080/13645706.2025.2467805
Publisher
Taylor & Francis
License
Journal
Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy
Volume
34
Issue
4
PubMed ID
ISSN
1365-2931